Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

PHASE4CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Rotavirus Gastroenteritis
Interventions
BIOLOGICAL

Human Rotavirus Vaccine

Rotavirus vaccine will be administered concomitantly with other routine Expanded Programme on Immunization (EPI) vaccinations at 6 \& 10 weeks of age, 10 \& 14 weeks of age, or 6, 10, \& 14 weeks of age, depending on study arm assignment.

Trial Locations (1)

Unknown

Navrongo Health Research Center, Navrongo

Sponsors
All Listed Sponsors
collaborator

Noguchi Memorial Institute for Medical Research

OTHER

collaborator

Navrongo Health Research Center

UNKNOWN

collaborator

Centers for Disease Control and Prevention

FED

lead

PATH

OTHER